Resveratrol shows efficacy in 2 diabetes studies

09/20/2013 | NutraIngredients

Type 2 diabetes patients who received oral hypoglycemic agents and resveratrol supplements attained significant improvements in body weight, oxidative stress and lipid profile compared with those who received only oral hypoglycemic agents, according to a study in the International Research Journal of Pharmacy. Another study, published in the journal Evidence-Based Complementary and Alternative Medicine, showed short-term use of resveratrol fared better than placebo in curbing blood glucose and insulin levels in patients with type 2 diabetes.

View Full Article in:

NutraIngredients

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID